Otto von Guericke University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Magdeburg Germany (1993)

Organization Overview

First Clinical Trial
2001
NCT00226473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dept. of Dermatology, University Otto von Guericke, Leipziger Strasse 44, D-39120 Magdeburg, Germany | Medizinische Fakultät d. Otto-v-Guericke-Universität Magdeburg, MVZ Diaverum Am Neuen Garten Potsdam | Otto-von Guericke Universitaet, Uniklinik Magdeburg | Otto-von-Guericke University - Magdeburg - Germany | Otto-von-Guericke-University of Magdeburg | Otto-von-Guericke-University of Magdeburg/Germany, Clinic for Dermatology and Venereology | University Otto von Guericke

Active Ingredients

Drugs in Phase 4 Trials (5)

cisplatin (platinol) (1 trial)

dacarbazine (dtic-dome) (1 trial)

diclofenac (voltaren) (2 trials)

imiquimod (aldara) (2 trials)

vindesine (Eldisine) (1 trial)

Drugs in Phase 3 Trials (1)

adapalene (differin) (1 trial)

Drugs in Phase 2 Trials (1)

isis 678354 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Melanoma (Phase 4)

Neoplasm Metastasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7